| UROGEN PHARMA LTD IS -,01 |
| Israel |
| Gesundheit |
| IL0011407140 / A2DTCV |
| UR8 (Frankfurt) / URGN (NASDAQ) |
| FRA:UR8, ETR:UR8, UR8:GR, NASDAQ:URGN |
| - |
| https://www.urogen.com/ |
|
UroGen Pharma Ltd. is an Israel-based biopharmaceutical company specializing in innovative treatments for urological cancers and diseases. The company develops therapies using its proprietary RTGel reverse-thermal hydrogel technology, a sustained-rel..
>Volltext.. |
| 1630.51 Mio. EUR |
| 1678.45 Mio. EUR |
| 121.84 Mio. EUR |
| -91.62 Mio. EUR |
| -115.53 Mio. EUR |
| -2.39 EUR |
| 170.92 Mio. EUR |
| 96.52 Mio. EUR |
| -152.27 Mio. EUR |
| 2.8 |
| 43.19% |
| 9.88% |
| - |
| - |
| - |
| UROGEN PHARMA |
| 05.08.26 |